Gongjin Wu

Lanzhou University Second Hospital

Papers

1

Total Citations

7

H-Index

1

About

Dr. Gongjin Wu is a pioneering urologic surgeon whose research focuses on advancing surgical techniques for bladder cancer treatment, particularly through robotic-assisted procedures and innovative urinary diversion methods. His most cited work, a 2024 study on perioperative outcomes and continence following robotic-assisted radical cystectomy (RARC) with Mainz pouch II urinary diversion, represents a significant contribution to the field. This research addresses a critical gap in the literature by systematically evaluating the functional outcomes and safety profile of this combined approach in 37 bladder cancer patients. With 7 citations already, the study has quickly gained attention for its practical insights into improving patient quality of life post-surgery. Dr. Wu’s work demonstrates how robotic technology can be integrated with continent urinary diversion techniques to enhance recovery and continence rates, offering a promising alternative to traditional methods. His findings are particularly valuable for surgeons seeking to optimize outcomes in complex urologic oncology cases. By documenting both the feasibility and efficacy of this surgical strategy, Dr. Wu is helping shape evidence-based practices in bladder cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Perioperative outcomes and continence following robotic-assisted radical cystectomy with mainz pouch II urinary diversion in patients with bladder cancer
7 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Lanzhou University Second Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago